Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism.
Antigen-Presenting-Cells, Bone-Marrow-Cells, Cell-Differentiation, Cell-Line-Tumor, Cricetinae, Half-Life, Homeostasis, Immunoglobulin-G, Mice-Knockout, Organ-Specificity, Receptors-Fc
J Immunol 2007 Oct; 179(7):4580-8.
The neonatal FcR (FcRn) is a receptor that protects IgG from catabolism and is important in maintaining high serum Ab levels. A major site of expression of FcRn is vascular endothelial cells where FcRn functions to extend the serum persistence of IgG by recycling internalized IgG back to the surface. Because FcRn is expressed in other tissues, it is unclear whether endothelial cells are the only site of IgG protection. In this study, we used FcRn-deficient mice and specific antiserum to determine the tissue distribution of FcRn in the adult mouse. In addition to its expression in the vascular endothelium of several organs, we found FcRn to be highly expressed in bone marrow-derived cells and professional APCs in different tissues. Experiments using bone marrow chimeras showed that FcRn expression in these cells acted to significantly extend the half-life of serum IgG indicating that in addition to the vascular endothelium, bone marrow-derived phagocytic cells are a major site of IgG homeostasis.
Akilesh, S; Christianson, G J.; Roopenian, D C.; and Shaw, A S., "Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism." (2007). Faculty Research 2000 - 2009. 1618.